Coagulating More Revenue
Linkedin

Coagulating More Revenue

Brussels : Belgium | Sep 26, 2012 at 12:10 PM PDT
Source: The Motley Fool
XX XX
Views: Pending
 
And when the drug was used as a prophylactic, annualized bleeding rates were between 1.38 and 2.95 episodes per year compared to 17.69 for the group that only used the drug as a treatment. The drug replaces a deficiency of Factor IX protein that occurs in patients with hemophilia B. FULL ARTICLE AT The Motley Fool
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.